Julie Wolf

Julie Wolf

Julie Wolf is the ASM Science Communications Specialist. She contributes to the ASM social media and blog network and hosts the Meet the Microbiologist podcast. She also runs workshops at ASM conferences to help scientists improve their own communication skills. Follow Julie on Twitter for more ASM and microbiology highlights at @JulieMarieWolf.

Julie earned her Ph.D. from the University of Minnesota, focusing on medical mycology and infectious disease. Outside of her work at ASM, she maintains a strong commitment to scientific education and teaches molecular biology at the community biolab, Genspace. She lives in beautiful New York City.

What is it like to treat Ebola patients while the nation watches? Colleen Kraft talks about treating the Americans who were evacuated from west Africa during the Ebola epidemic.

A recent Antimicrobial Agents and Chemotherapy study undertook a meta-analysis of data from around the world to better identify common risk factors for carbapenem-resistent Enterobacteriaceae infection - and to identify ways to control outbreaks.

How does biological sex influence influenza infection and vaccination?

The most popular posts here at mBiosphere this year covered the influence of the microbial sciences research on food preparation, infectious disease management, emerging diseases, and immune influence – truly illustrating the broad reach of microbiology! 

 

Jennifer Martiny describes the incredible microbial biodiversity of natural ecosystems such as soils and waterways.

Peter Hotez talks about neglected tropical diseases: what are they, where are they found, and where did the term “neglected tropical disease” come from, anyway?

For over 100 years, Histoplasma capsulatum was thought to be a single fungal species with several variant strain variations. New analyses of genome sequences reveal the genus Histoplasma contains at least four species, and may contain more.

A cure for HIV infection remains elusive. A new model to study HIV reactivation in quiescent cells, described in Journal of Virology, may help researchers better understand infection and devise effective treatment strategies.

Persistence, like antibiotic resistance, can lead to drug failure when treating bacterial infections. A new Antimicrobial Agent and Chemotherapy study extends previous findings that a drug-metabolite cocktail may increase drug efficiency when treating Pseudomonas aeruginosa

Stacey Schultz-Cherry explains the selection process to choose the influenza virus strains to include in the annual influenza vaccine.

Page 1 of 10

TPL_asm2013_SEARCH

59565:juliewolf

Joomla! Debug Console

Session

Profile Information

Memory Usage

Database Queries